Posted by Michael Wonder on 29 Mar 2019
Canada’s amendment to patented drug price regulation: a prescription for global drug cost control?
29 March 2019 - The cost of drugs in the United States has emerged as a focal point for reducing overall health care costs.
Canada, like many countries around the globe, is experiencing rising health care costs (with markedly increasing prescription drug prices as the main driver of cost) and may provide an example for the United States and other countries as an approach to controlling the cost of drugs.
The pharmaceutical industry has evolved significantly in recent years, with specialised biologic and genetic therapies among the most rapidly growing drug classes. These therapies are often accompanied by high drug prices, which create an obstacle for patients in accessing innovative treatments. In line with the changing landscape of health technologies, pricing and reimbursement models must evolve to provide patients with access to promising new treatments and ensure the sustainability of health care systems.
